| Name | Title | Contact Details |
|---|
Since day one, we`ve been dedicated to delivering personalized, innovative, and impactful workplace wellness programs. Provant is a health and wellness solutions company that partners with businesses to build cultures of health designed to improve the health, well-being, and productivity of employees while supporting employers with their healthcare affordability agenda. Provant`s Life+ Program combines personalized “high touch” services with powerful social networking tools that link rewards to healthy behaviors and outcomes. The results of these programs: exceptional engagement, improved health, productive employees, and lower costs. Founded in 2001, Provant serves customers of all sizes across the United States, Puerto Rico, Canada, and the Caribbean. Our customizable program is delivered to millions of people and consist of assessment services (e.g. screening services, flu vaccinations), inspirational services (e.g. coaching, lifestyle and condition programs) and reward and reporting services (participation-based and outcome-based programs). Program innovation, customization, and a comprehensive, quality approach to managing health risks are at the cornerstone of everything that we do. Our leadership team consists of seasoned wellness and business professionals with extensive experience in the health promotion, wellness, consumerism, medical, insurance, and hospital arenas. Our commitment to what we do is based on a sincere desire to promote wellness, to partner with our clients, and to work as a team. Improving lives in the process is what makes it all worthwhile.
Madame Vanier Children's Services is a London, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NanoGuardian is a Skokie, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Abeona Therapeutics is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. Abeona’s lead program is an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome (MPS IIIA and IIIB) in collaboration with patient advocate groups, researchers and clinicians. Clinical trials for Sanfilippo types A and B are anticipated to begin in 2015.
Wintersun Chemical is a Ontario, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.